TCRCure (天科雅)
Beijing, China
TCRCure aims to develop next generation cancer immunotherapies that control tumor progression, convert cancers to manageable chronic diseases, and eventually lead to a cure. TCRCure is a leading international company focused on streamlined biotechnology development including high throughput antigen-specific TCR cloning, industry scale virus production, T cell genetic engineering, and immune cell manufacturing. TCRCure’s deep sequencing and big data analysis platform supports immune monitoring services. This service can provide valuable data to pharmaceutical companies running clinical trials on immunotherapy drugs. TCRCure has already provided this service to many well-known pharmaceutical companies including BMS.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2016
- Website
- en.tcrcure.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of TCRCure (天科雅)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now